Manchester Heart Centre recruits first patient in the UK trial to optimise technology for patients with heart implants
Congratulations to Dr Amir Zaidi Consultant Cardiologist and his research team at the Manchester Heart Centre for recruiting the first patient in the UK to the SMART registry study.
This international study will compare the device settings in around 2000 people living with an irregular heart rhythm and fitted with a Boston Scientific Quadripolar Cardiac Resynchronisation Therapy Defibrillator (CRT-D) system.
An implanted CRT-D is a small medical device which detects heart rate irregularities, such as missing a beat or an abnormally fast rhythm, and works by quickly emitting tiny pulses of electricity to correct them. Results will be compared across a 12 month period to find the optimum pacing configurations.
The study is sponsored by Guidant Europe NV (a Boston Scientific Company) and supported by the National Institute for Health Research Clinical Research Network.